Edwin Rock's most recent trade in GlycoMimetics Inc was a trade of 190,000 Common Stock done at an average price of $0.3 . Disclosure was reported to the exchange on June 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 20 Jun 2024 | 190,000 | 565,403 (1%) | 0% | 0.3 | 48,108 | Common Stock | |
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 20 Jun 2024 | 115,000 | 680,403 (1%) | 0% | 0.3 | 30,717 | Common Stock | |
GlycoMimetics Inc | Rock Edwin | Chief Medical Officer | 12 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 21 Sep 2023 | 35,000 | 345,000 (0%) | 0% | 1.4 | 48,300 | Common Stock | |
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 21 Sep 2023 | 30,403 | 375,403 (0%) | 0% | 1.4 | 41,956 | Common Stock | |
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 19 Jan 2023 | 244,800 | 244,800 | - | - | Employee Stock Option (right to buy) | ||
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 22 Dec 2022 | 110,000 | 310,000 (0%) | 0% | 2.3 | 247,500 | Common Stock | |
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 14 Nov 2022 | 100,000 | 100,000 (0%) | 0% | 1.4 | 143,000 | Common Stock | |
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 14 Nov 2022 | 100,000 | 200,000 (0%) | 0% | 1.7 | 166,000 | Common Stock | |
GlycoMimetics Inc | Edwin Rock | Chief Medical Officer | 02 Sep 2022 | 200,000 | 200,000 | - | - | Employee stock option (right to buy) |